{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.582","meta":{"versionId":"7","lastUpdated":"2023-04-03T15:53:47.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CancerLinQ Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-04-03"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.582","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1116.582"}],"version":"20190319","name":"ReasonForNotAdministeringTrastuzumabDocumented","title":"Reason for not administering Trastuzumab documented","status":"active","experimental":false,"date":"2019-03-19T01:00:22-04:00","publisher":"CancerLinQ Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","concept":[{"code":"G9836","display":"Reason for not administering trastuzumab documented (e.g. patient declined, patient died, patient transferred, contraindication or other clinical exclusion, neoadjuvant chemotherapy or radiation not complete)"}]}]},"expansion":{"identifier":"urn:uuid:1b49f747-72ae-4591-92a4-ab8dde1d2e4d","timestamp":"2023-12-10T21:43:00-05:00","total":0}}